title: Escherichia coli-asparaginase (Elspar) is superior to Erwinia-asparaginase (Erwinase) in childhood acute lymphoblastic leukaemia (ALL) induction--an early response study using minimal residual disease (MRD) markers.
authors.affiliation: Division of Paediatric Haematology-Oncology, The Children's Medical Institute National University Hospital, National University of Singapore.
authors.forename: C S N
authors.initials: CS
authors.lastname: Kwok
authors.forename: S K Y
authors.initials: SK
authors.lastname: Kham
authors.forename: H
authors.initials: H
authors.lastname: Ariffin
authors.forename: H P
authors.initials: HP
authors.lastname: Lin
authors.forename: T C
authors.initials: TC
authors.lastname: Quah
authors.forename: A E J
authors.initials: AE
authors.lastname: Yeoh
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D016974:Dickeya chrysanthemi / Q000201:enzymology; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000187:drug effects; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents; D001215:Asparaginase